A Case of Behcet's Disease with Splenic Infarction

비장경색이 동반된 베체트병 1예

  • Jung, Jang-Han (Division of Rheumatology, Department of Internal Medicine, Konyang University College of Medicine) ;
  • Kang, Min-Kyu (Division of Rheumatology, Department of Internal Medicine, Konyang University College of Medicine) ;
  • Lee, Han-Na (Division of Rheumatology, Department of Internal Medicine, Konyang University College of Medicine) ;
  • Kwon, Mi-Hye (Division of Rheumatology, Department of Internal Medicine, Konyang University College of Medicine) ;
  • Joung, Chung-Il (Division of Rheumatology, Department of Internal Medicine, Konyang University College of Medicine)
  • 정장한 (건양대학교 의과대학 류마티스내과학교실) ;
  • 강민규 (건양대학교 의과대학 류마티스내과학교실) ;
  • 이한나 (건양대학교 의과대학 류마티스내과학교실) ;
  • 권미혜 (건양대학교 의과대학 류마티스내과학교실) ;
  • 정청일 (건양대학교 의과대학 류마티스내과학교실)
  • Published : 2011.07.01

Abstract

Behcet's disease is a multisystem autoimmune disease with vasculitic features, and major vascular involvement occurs in 7.7-60% of patients. Venous lesions are more common than arterial lesions and arterial thrombotic events are relatively rare. We report a patient with Behcet's disease who developed a splenic infarct associated with splenic thrombotic arteritis. A 44-year-old man who had been diagnosed with Behcet's disease 5 years earlier presented with left flank pain lasting for 5 days. Laboratory tests revealed an elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Computed tomography (CT) and three-dimensional CT showed a wedge-shaped splenic infarct and thrombus in the splenic artery. We treated him with low-molecular-weight heparin and prednisolone. The symptoms improved within 6 days of hospitalization, after which we stopped the heparin and added methotrexate and azathioprine. Splenic infarct should be ruled out if patients with Behcet's disease complain of new left-sided abdominal pain.

베체트병을 진단 받았거나, 의심되는 환자에서 왼쪽 옆구리 통증이 동반될 경우, 혈전성 혈관염에 동반된 비장 경색을 감별해야 하겠다.

Keywords

References

  1. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL. Harrison's Principles of Internal Medicine. 17th ed. New York: McGraw-Hill, 2007.
  2. Hamza M. Large artery involvement in Behçet's disease. J Rheumatol 1987;14:554-559.
  3. Koc Y, Gullu I, Akpek G, et al. Vascular involvement in Behcet's disease. J Rheumatol 1992;19:402-410.
  4. Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behcet's disease. Semin Arthritis Rheum 1998;27:197-217. https://doi.org/10.1016/S0049-0172(98)80001-2
  5. Lie JT. Vascular involvement in Behcet's disease: arterial and venous and vessels of all sizes. J Rheumatol 1992;19:341-343.
  6. Ames PR, Stuer A, Pap A, Denman AM. Thrombosis in Behcet's disease: a retrospective survey from a single UK centre. Rheumatology 2001;40:652-655. https://doi.org/10.1093/rheumatology/40.6.652
  7. 서정민, 유옥현, 이성, 고용복. 혈관 Behcet씨병 35예에 대한 고찰. 대한맥관외과학회지 1995;11:257-263.
  8. Ozoran K, Duzgun N, Gurler A, Tutkak H, Tokgoz G. Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behcet's disease. Scand J Rheumatol 1995;24:376-382. https://doi.org/10.3109/03009749509095184
  9. 강성욱, 신기철, 이윤종 등. 베체트병에서의 혈액응고 이상에 관한 연구. 대한류마티스학회지 1999;6:227-237.
  10. Klippel JH, Dieppel PA. Rheumatology. 2nd ed. Baltmore: Mosby, 1998.
  11. Orem A, Deger O, Memis O, Caliskan K, Cimsit G. High lipoprotein (a) levels as a thrombogenic risk factor in Behcet's disease. Ann Rheum Dis 1994;53:351-352. https://doi.org/10.1136/ard.53.5.351
  12. Mohri M, Sata M, Gomi K, Maruyama Y, Osame M, Maruyama I. Abnormalities in the protein C anticoagulant pathway detected by a novel assay using thrombomodulin. Lupus 1997;6:590-596. https://doi.org/10.1177/096120339700600706
  13. Lenk N, Ozet G, Alli N, Coban O, Erbasi S. Protein C and protein S activities in Behcet's disease as risk factors of thrombosis. Int J Dermatol 1998;37:124-125. https://doi.org/10.1046/j.1365-4362.1998.00114.x
  14. Antopolsky M, Hiller N, Salameh S, Goldshtein B, Stainikowicz R. Splenic infarction: 10 years of experience. Am J Emerg Med 2009;27:262-265. https://doi.org/10.1016/j.ajem.2008.02.014